{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:28:35Z","timestamp":1787682515025,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bcp.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T12:04:54Z","timestamp":1402488294000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms"],"prefix":"10.1016","volume":"91","author":[{"given":"Jong-Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongjun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-9982","authenticated-orcid":false,"given":"Hyunil","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zang Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.06.005_bib0005","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2014.06.005_bib0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2014.06.005_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/cbt.7.1.5163","article-title":"Biology of breast cancer bone metastasis","volume":"7","author":"Akhtari","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bcp.2014.06.005_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bcp.2014.06.005_bib0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2014.06.005_bib0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2014.06.005_bib0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1535-6108(03)00310-6","article-title":"Targeting cyclooxygenase-2 in human neoplasia: rationale and promise","volume":"4","author":"Dannenberg","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2014.06.005_bib0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0165-6147(02)00043-3","article-title":"Cyclooxygenase 2: a molecular target for cancer prevention and treatment","volume":"24","author":"Subbaramaiah","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2014.06.005_bib0045","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/endo.141.4.7405","article-title":"The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs","volume":"141","author":"Suzawa","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2014.06.005_bib0050","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1158\/0008-5472.CAN-05-2012","article-title":"Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer","volume":"66","author":"Hiraga","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.06.005_bib0055","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1359\/jbmr.2002.17.5.774","article-title":"Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines","volume":"17","author":"Ono","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bcp.2014.06.005_bib0060","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0006-291X(02)02937-6","article-title":"Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis","volume":"300","author":"Ohshiba","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2014.06.005_bib0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.febslet.2007.01.005","article-title":"Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells","volume":"581","author":"Takita","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2014.06.005_bib0070","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2004-05-1772","article-title":"Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines","volume":"105","author":"Diaz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.06.005_bib0075","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1038\/sj.leu.2404891","article-title":"Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity","volume":"21","author":"Diaz","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2014.06.005_bib0080","first-page":"245","article-title":"Inhibitory effect of Trolox on the migration and invasion of human lung and cervical cancer cells","volume":"29","author":"Sung","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bcp.2014.06.005_bib0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000338490","article-title":"Trolox enhances curcumin's cytotoxicity through induction of oxidative stress","volume":"29","author":"Zheng","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.bcp.2014.06.005_bib0090","doi-asserted-by":"crossref","first-page":"13725","DOI":"10.1074\/jbc.M806941200","article-title":"Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling","volume":"284","author":"Lee","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.06.005_bib0095","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1158\/0008-5472.CAN-12-0481","article-title":"CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis","volume":"72","author":"Lee","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.06.005_bib0100","first-page":"1393","article-title":"COX-2 overexpression increases motility and invasion of breast cancer cells","volume":"26","author":"Singh","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2014.06.005_bib0105","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1074\/jbc.M600184200","article-title":"NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2","volume":"281","author":"Yiu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.06.005_bib0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2407-6-181","article-title":"Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression","volume":"6","author":"Larkins","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2014.06.005_bib0115","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2014.06.005_bib0120","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2014.06.005_bib0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ccr.2010.12.022","article-title":"Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells","volume":"19","author":"Sethi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2014.06.005_bib0130","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1440-1681.2006.04481.x","article-title":"Effects of Trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy","volume":"33","author":"Sharma","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bcp.2014.06.005_bib0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1179\/016164107X158983","article-title":"Neuroprotective effects of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), an antioxidant in middle cerebral artery occlusion induced focal cerebral ischemia in rats","volume":"29","author":"Sharma","year":"2007","journal-title":"Neurol Res"},{"key":"10.1016\/j.bcp.2014.06.005_bib0140","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S8756-3282(03)00264-3","article-title":"The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines","volume":"33","author":"Ono","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2014.06.005_bib0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S8756-3282(97)00033-1","article-title":"Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow","volume":"20","author":"Weinreb","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2014.06.005_bib0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1677\/joe.0.1560051","article-title":"Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae","volume":"156","author":"Suponitzky","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bcp.2014.06.005_bib0155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1359\/jbmr.2002.17.6.963","article-title":"Cyclo-oxygenase 2 function is essential for bone fracture healing","volume":"17","author":"Simon","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bcp.2014.06.005_bib0160","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jbmr.5650111112","article-title":"Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo","volume":"11","author":"Forwood","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bcp.2014.06.005_bib0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ceb.2011.12.004","article-title":"Directed cell invasion and migration during metastasis","volume":"24","author":"Bravo-Cordero","year":"2012","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.bcp.2014.06.005_bib0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/carcin\/bgp205","article-title":"Cancer-preventive activities of tocopherols and tocotrienols","volume":"31","author":"Ju","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2014.06.005_bib0175","doi-asserted-by":"crossref","first-page":"20464","DOI":"10.1073\/pnas.0810962106","article-title":"Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases","volume":"105","author":"Jiang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2014.06.005_bib0180","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2659","article-title":"Vitamin E decreases bone mass by stimulating osteoclast fusion","volume":"18","author":"Fujita","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2014.06.005_bib0185","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00774-010-0159-2","article-title":"Beneficial effects of vitamin E isomer supplementation on static and dynamic bone histomorphometry parameters in normal male rats","volume":"28","author":"Mehat","year":"2010","journal-title":"J Bone Miner Metab"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214003487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214003487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T09:24:18Z","timestamp":1538558658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214003487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0006295214003487"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.06.005","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}